Longer intervals between SARS‐CoV‐2 infection and mRNA‐1273 doses improve the neutralization of different variants of concern by García‐Pérez, Javier, Bermejo, Mercedes, Ramírez‐García, Almudena, De La Torre‐Tarazona, Humberto Erick, Cascajero, Almudena, Castillo de la Osa, María, Jiménez, Paloma, Aparicio Gómez, Marta, Calonge, Esther, Sancho‐López, Aránzazu, Payares‐Herrera, Concepción, Layunta Acero, Rocio, Vicente‐Izquierdo, Laura, Avendaño‐Solá, Cristina, Alcamí, José, Pérez‐Olmeda, Mayte, Díez‐Fuertes, Francisco

Get full text

Transcriptome Sequencing of Peripheral Blood Mononuclear Cells from Elite Controller-Long Term Non Progressors by Díez-Fuertes, Francisco, De La Torre-Tarazona, Humberto Erick, Calonge, Esther, Pernas, Maria, Alonso-Socas, María del Mar, Capa, Laura, García-Pérez, Javier, Sakuntabhai, Anavaj, Alcamí, José

Get full text

Insight in miRNome of Long-Term Non-Progressors and Elite Controllers Exposes Potential RNAi Role in Restraining HIV-1 Infection by Ayala-Suárez, Rubén, Díez-Fuertes, Francisco, Calonge, Esther, De La Torre Tarazona, Humberto, Gracia-Ruíz de Alda, María, Capa, Laura, Alcamí, José

Get full text

Elite controllers long-term non progressors present improved survival and slower disease progression by Capa, Laura, Ayala-Suárez, Rubén, De La Torre Tarazona, Humberto Erick, González-García, Juan, del Romero, Jorge, Alcamí, José, Díez-Fuertes, Francisco

Get full text

Novel association of five HLA alleles with HIV-1 progression in Spanish long-term non progressor patients by Ramírez de Arellano, Eva, Díez-Fuertes, Francisco, Aguilar, Francisco, de la Torre Tarazona, Humberto Erick, Sánchez-Lara, Susana, Lao, Yolanda, Vicario, José Luis, García, Felipe, González-Garcia, Juan, Pulido, Federico, Gutierrez-Rodero, Félix, Moreno, Santiago, Iribarren, Jose Antonio, Viciana, Pompeyo, Vilches, Carlos, Ramos, Manuel, Capa, Laura, Alcamí, José, Del Val, Margarita

Get full text

Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study by García-Pérez, Javier, González-Pérez, María, Castillo de la Osa, María, Borobia, Alberto M., Castaño, Luis, Bertrán, María Jesús, Campins, Magdalena, Portolés, Antonio, Lora, David, Bermejo, Mercedes, Conde, Patricia, Hernández-Gutierrez, Lourdes, Carcas, Antonio, Arana-Arri, Eunate, Tortajada, Marta, Fuentes, Inmaculada, Ascaso, Ana, García-Morales, María Teresa, Erick de la Torre-Tarazona, Humberto, Arribas, José-Ramón, Imaz-Ayo, Natale, Mellado-Pau, Eugènia, Agustí, Antonia, Pérez-Ingidua, Carla, Gómez de la Cámara, Agustín, Ochando, Jordi, Belda-Iniesta, Cristobal, Frías, Jesús, Alcamí, José, Pérez-Olmeda, Mayte

Get full text

Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT1... by Ascaso-del-Rio, Ana, García-Pérez, Javier, Pérez-Olmeda, Mayte, Arana-Arri, Eunate, Vergara, Itziar, Pérez-Ingidua, Carla, Bermejo, Mercedes, Castillo de la Osa, María, Imaz-Ayo, Natale, Riaño Fernández, Ioana, Astasio González, Oliver, Díez-Fuertes, Francisco, Meijide, Susana, Arrizabalaga, Julio, Hernández Gutiérrez, Lourdes, de la Torre-Tarazona, Humberto Erick, Mariano Lázaro, Alberto, Vargas-Castrillón, Emilio, Alcamí, José, Portolés, Antonio

Get full text